[Federal Register Volume 86, Number 94 (Tuesday, May 18, 2021)]
[Notices]
[Page 26943]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-10412]



[[Page 26943]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-835]


Bulk Manufacturer of Controlled Substances Application: SPECGX 
LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: SPECGX LLC, has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before July 19, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before July 19, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on February 5, 2021, SPECGX LLC, 3600 N 2nd Street, 
Saint Louis, Missouri 63147, applied to be registered as a bulk 
manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
           Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid................            2010  I
Tetrahydrocannabinols....................            7370  I
Codeine-N-oxide..........................            9053  I
Dihydromorphine..........................            9145  I
Difenoxin................................            9168  I
Morphine-N-oxide.........................            9307  I
Normorphine..............................            9313  I
Alphamethadol............................            9605  I
Betamethadol.............................            9609  I
Norlevorphanol...........................            9634  I
Acetyl Fentanyl (N-(1-phenethylpiperidin-            9821  I
 4-yl)-N-phenylacetamide).
Butyryl Fentanyl.........................            9822  I
Fentanyl related-compounds as defined in             9850  I
 21 CFR 1308.11(h).
Amphetamine..............................            1100  II
Methamphetamine..........................            1105  II
Lisdexamfetamine.........................            1205  II
Methylphenidate..........................            1724  II
Nabilone.................................            7379  II
ANPP (4-Anilino-N-phenethyl-4-piperidine)            8333  II
Codeine..................................            9050  II
Dihydrocodeine...........................            9120  II
Oxycodone................................            9143  II
Hydromorphone............................            9150  II
Diphenoxylate............................            9170  II
Ecgonine.................................            9180  II
Hydrocodone..............................            9193  II
Levorphanol..............................            9220  II
Meperidine...............................            9230  II
Meperidine intermediate-A................            9232  II
Meperidine intermediate-B................            9233  II
Meperidine intermediate-C................            9234  II
Methadone................................            9250  II
Methadone intermediate...................            9254  II
Dextropropoxyphene, bulk (non-dosage                 9273  II
 forms).
Morphine.................................            9300  II
Oripavine................................            9330  II
Thebaine.................................            9333  II
Opium tincture...........................            9630  II
Opium, powdered..........................            9639  II
Oxymorphone..............................            9652  II
Noroxymorphone...........................            9668  II
Alfentanil...............................            9737  II
Remifentanil.............................            9739  II
Sufentanil...............................            9740  II
Tapentadol...............................            9780  II
Fentanyl.................................            9801  II
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substances for the internal use intermediates or for sale to its 
customers. In reference to dug code 7370 (Tetrahydrocannabinols), the 
company plans to bulk manufacture this drug as synthetic. No other 
activities for these drug codes are authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-10412 Filed 5-17-21; 8:45 am]
BILLING CODE P